The interaction between CAFs and cancer cells determines ECM stiffness or degradation, which can produce TGF-β for ECM stiffness and matrix metalloproteinases (MMPs) for ECM degradation; both promote the proliferation, metastasis and angiogenesis of cancer cells. The gene discussed is TGFB1; the disease is cancer.